ReviewCellular & molecular biology letters2026
Post-translational modifications of selective autophagy receptors: orchestrating cellular homeostasis, disease pathogenesis, and therapeutic opportunities.
Review in Cellular & molecular biology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Autophagy Modulation in Cancer Therapy: Navigating the Dual Roles to Overcome Chemoresistance.Health science reports · 2026Article
- SQSTM1/p62 UFMylation Enhances Autophagic Clearance of Pathogenic Mutant Huntingtin.International journal of biological sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Selective autophagy, an evolutionarily conserved quality control process, preserves cellular homeostasis by degrading specific substrates or organelles. Autophagy receptors, which precisely recognize and target substrates through sophisticated molecular mechanisms, are central to this pathway. These receptors orchestrate diverse biological functions ranging from DNA damage response, protein degradation, proteostasis, neuronal health, to immune modulation. Increasing evidence suggests that posttranslational modifications (PTMs) critically regulate the biological functions of autophagy receptors, forming a complex regulatory network that remains incompletely characterized in disease pathogenesis. This review first summarizes current knowledge of mammalian autophagy, including the principal molecular machinery across diverse pathways. We then categorize autophagy receptors on the basis of cargo specificity, and highlight PTM-mediated regulatory mechanisms. Furthermore, we explore their pathophysiological roles and assess their therapeutic potential by integrating recent advances. Finally, we discuss emerging perspectives in the autophagy research field, especially for the discovery of pathology-associated PTMs that modulate the functions of autophagy receptors. A deeper understanding of autophagic regulation and its pathophysiological significance will advance innovative therapeutic strategies targeting diseases associated with autophagy dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.